~~<i id='6CABED06C8'><strike id='6CABED06C8'><tt id='6CABED06C8'><pre id='6CABED06C8'></pre></tt></strike></i>~~

Home» Wikipedia» hotspot

hotspot

author：focus 2025-09-27 09:19:00 Page View：62

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Michigan man accused of striking an officer during the US Capitol attack is arrested in Florida
Next article： Medicare details structure of new drug price negotiation program

explore

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

AdobeSometimes,anappleadayreallyisjustwhatthedoctorordered.Andforthepastseveralyears,organizationsli

Anavex keeps shifting the goalposts in its clinical trials

MollyFerguson/STATAnavexLifeSciencesisinatoughspot.Theserialdissemblerofclinicaltrialresultsmightbef

Medical records are filled with copy

AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

Listen: Merck v. USA, the best of ASCO, and Leqembi at the FDA

SammyKimballforSTATAredrugpricesprotectedbytheConstitution?WillMedicareembraceAlzheimer’sdiseasetrea